Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy
Youqiong Ye, Qingsong Hu, Hu Chen, et al.
Nature Metabolism (2019) Vol. 1, Iss. 4, pp. 431-444
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 521
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
Ellen C. de Heer, Mathilde Jalving, Adrian L. Harris
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5074-5087
Open Access | Times Cited: 277
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhao Zhang, Joo‐Hyung Lee, Hang Ruan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 205
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 196
Sex-associated molecular differences for cancer immunotherapy
Youqiong Ye, Ying Jing, Li Liang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 194
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
Raefa Abou Khouzam, Klaudia Brodaczewska, Aleksandra Filipiak-Duliban, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 153
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 153
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines
Hang Ruan, Yu Xiang, Junsuk Ko, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 149
A General Approach to Design Dual Ratiometric Fluorescent and Photoacoustic Probes for Quantitatively Visualizing Tumor Hypoxia Levels In Vivo
Shuping Zhang, Hua Chen, Liping Wang, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 7
Closed Access | Times Cited: 106
Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis
Zhenzhen Xun, Xinyu Ding, Yao Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 71
Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA
Jian Hu, Kyle Coleman, Daiwei Zhang, et al.
Cell Systems (2023) Vol. 14, Iss. 5, pp. 404-417.e4
Open Access | Times Cited: 54
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 17
Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains
Chengxuan Chen, Zhao Zhang, Yuan Liu, et al.
Science Advances (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Tumour hypoxia in driving genomic instability and tumour evolution
Alexandru Suvac, Jack Ashton, Robert G. Bristow
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Oxygen‐Enriched Metal‐Phenolic X‐Ray Nanoprocessor for Cancer Radio‐Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy
Wei Sang, Lisi Xie, Guohao Wang, et al.
Advanced Science (2020) Vol. 8, Iss. 4
Open Access | Times Cited: 130
Immune escape: A critical hallmark in solid tumors
Keywan Mortezaee
Life Sciences (2020) Vol. 258, pp. 118110-118110
Closed Access | Times Cited: 125
Divergent mutational processes distinguish hypoxic and normoxic tumours
Vinayak Bhandari, Constance H. Li, Robert G. Bristow, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 118
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
Zhaowu Ma, Xiaoqiang Xiang, Shiya Li, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 379-390
Closed Access | Times Cited: 115
Endogenous Hydrogen Sulfide-Triggered MOF-Based Nanoenzyme for Synergic Cancer Therapy
Yite Li, Junli Zhou, Lei Wang, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 27, pp. 30213-30220
Closed Access | Times Cited: 103
Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers
Mark A. Rubin, Robert G. Bristow, Phillip Thienger, et al.
Molecular Cell (2020) Vol. 80, Iss. 4, pp. 562-577
Open Access | Times Cited: 102
Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data
Jinfen Wei, Kaitang Huang, Zixi Chen, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1788-1788
Open Access | Times Cited: 93
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy
Ying Jing, Yongchang Zhang, Jing Wang, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 10, pp. 1396-1404
Closed Access | Times Cited: 85
Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study
Jiannan Liu, Xiangshuo Kong, Tao Huang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 84
Novel Anthraquinone Compounds as Anticancer Agents and their Potential Mechanism
Wei Tian, Chunmiao Wang, Danrong Li, et al.
Future Medicinal Chemistry (2020) Vol. 12, Iss. 7, pp. 627-644
Closed Access | Times Cited: 79
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Tiansheng Li, Chao Mao, Xiang Wang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top